Department of General Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning Province, 110042, China.
Second Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning Province, 110042, China.
Adv Sci (Weinh). 2023 Sep;10(26):e2300824. doi: 10.1002/advs.202300824. Epub 2023 Jul 12.
In recent years, the incidence of gastrointestinal cancers is increasing, particularly in the younger population. Effective treatment is crucial for improving patients' survival outcomes. Programmed cell death, regulated by various genes, plays a fundamental role in the growth and development of organisms. It is also critical for maintaining tissue and organ homeostasis and takes part in multiple pathological processes. In addition to apoptosis, there are other types of programmed cell death, such as ferroptosis, necroptosis, and pyroptosis, which can induce severe inflammatory responses. Notably, besides apoptosis, ferroptosis, necroptosis, and pyroptosis also contribute to the occurrence and development of gastrointestinal cancers. This review aims to provide a comprehensive summary on the biological roles and molecular mechanisms of ferroptosis, necroptosis, and pyroptosis, as well as their regulators in gastrointestinal cancers and hope to open up new paths for tumor targeted therapy in the near future.
近年来,胃肠道癌症的发病率呈上升趋势,尤其在年轻人群中更为明显。有效的治疗对于改善患者的生存预后至关重要。程序性细胞死亡受多种基因调控,在生物体的生长发育中发挥着基础性作用,对维持组织和器官的稳态以及参与多种病理过程都具有重要意义。除了细胞凋亡外,还有其他类型的程序性细胞死亡,如铁死亡、坏死性凋亡和细胞焦亡,它们会引发严重的炎症反应。值得注意的是,除了细胞凋亡外,铁死亡、坏死性凋亡和细胞焦亡也与胃肠道癌症的发生和发展有关。本综述旨在全面总结铁死亡、坏死性凋亡和细胞焦亡的生物学作用和分子机制,以及它们在胃肠道癌症中的调控因子,并希望为未来的肿瘤靶向治疗开辟新的途径。
J Hematol Oncol. 2020-8-10
Front Immunol. 2022
Mater Today Bio. 2025-7-26
Cell Biosci. 2025-7-4
J Physiol Biochem. 2025-5-13
Drug Resist Updat. 2023-1
Nat Rev Nephrol. 2023-5
Nat Rev Nephrol. 2023-5
Pharmacol Res. 2023-1
Eur J Med Chem. 2023-2-5
Inflamm Res. 2023-2
Cancer Lett. 2023-2-28